3月30日晚间,新华制药(000756)公布2024年年报,公司营业收入为84.7亿元,同比上升4.5%;归母净利润为4.7亿元,同比下降5.3%;扣非归母净利润为4.48亿元,同比下降2.9%;经营现金流净额为3.68亿元,同比增长38.6%。公司拟以6.89亿股为基数,向全体股东每10股派发现金红利2.5元(含税)。其中第四季度,公司营业收入为17.3亿元,同比上升8.0%;归母净利润为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.